ALPK2

Health

A new therapeutic target for a lethal form of heart failure: ALPK2

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an…

Read More »
Back to top button